Catalent
Trending Articles
Related Content
Pharmaceutical
Catalent receives FDA approval as an additional manufacturing site for AveXis' Gene Therapy
The global provider of advanced drug delivery technologies will produce the commercial drug substance intermediate for AveXis’ spinal muscular atrophy (SMA) gene therapy at its manufacturing facility located in Harmans, Maryland
Containment
The rise of HPAPIs: Putting safety first
The increasing focus on highly potent active pharmaceutical ingredients (HPAPIs) in pharmaceutical development pipelines has led to a growing requirement for the capability to safely handle and contain these hazardous ingredients. Dr Kevin Robinson investigates